Genomics on the road to functional cure of hepatitis B

Hepatitis B virus (HBV) infection can be prevented, and the World Health Organization aims to eliminate HBV as a public health threat by 2030.1,2 However, mortality from HBV exceeds that from malaria and HIV, and is projected to rise sharply because an estimated 296 million persons already are living with chronic hepatitis B (PLWHB).1 –3 There are treatments for PLWHB, but none cures more than 10%.4,5 Identifying which of the 296 million will be cured by existing treatments and finding new cures for the rest are among the most important challenges in hepatitis elimination.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research